Plasma Gamma-Glutamyltransferase Is Strongly Determined by Acylation Stimulating Protein Levels Independent of Insulin Resistance in Patients with Acute Coronary Syndrome

Table 1

Differences in anthropometric and metabolic measures between acute coronary syndrome patients and controls.

Parameter	Controls	Patients	𝑃 value
T-Chol (mM)	5.0±0.15	4.9±0.18	0.62
TG (mM)	1.0±0.1	1.96±0.2	< 0.0001
HDL-C (mM)	1.4±0.05	1.15±0.09	0.028
LDL-C (mM)	3.33±0.16	3.22±0.16	0.64
LDL size (nm)	26.4±0.19	24.0±0.74	0.003
ApoA1 g/dL	1.33±0.03	1.15±0.04	0.003
ApoB g/dL	0.93±0.05	1.01±0.05	0.28
Insulin (mM)	5.75±0.62	11.04±2.3	0.02
Glucose (mM)	5.05±0.09	6.6±0.6	0.01
HOMA-IR	1.3±0.15	3.9±1.07	0.02
BMI	28.5±1.03	28.8±0.73	0.02
WC (cm)*
Males	92.8±3.0	98.8±3.1	0.17
Females	77.8±2.2	88.7±6.5	0.03
Bilirubin (µM)	4.4±0.6	2.7±0.32	0.02

Values are given as average ± standard error of the mean. Differences are significant at 𝑃<0.05.
∗WC measures identified as a metabolic syndrome component are (males WC > 101.6 cm; females: WC > 88.9 cm) [32].